Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto S Pappo

Showing results (61-70 of 136) with videos related to

Pageof 14
Sort By:
Cancer|January 22, 2005
The feasibility of adjuvant interferon alpha-2b in children with high-risk melanomaFariba Navid, Wayne L Furman, Martin Fleming, et al.
Journal of Pediatric Surgery|March 26, 2002
Perianal rhabdomyosarcoma presenting as a perirectal abscess: A report of 11 casesD Ashley Hill, Louis P Dehner, Kenneth W Gow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcomaSheri L Spunt, D Ashley Hill, Alison M Motosue, et al.
Pediatric Blood & Cancer|May 17, 2024
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332David P Douglass, Cheryl M Coffin, R Lor Randall, et al.
Pediatric Blood & Cancer|February 8, 2011
Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology GroupDavid O Walterhouse, Jane L Meza, John C Breneman, et al.
Sarcoma|July 7, 2015
Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective ReviewMichael W Bishop, Jessica M Somerville, Armita Bahrami, et al.
Cancer|March 17, 2006
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experienceFariba Navid, Victor M Santana, Catherine A Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudySeth J Rotz, Kayla Stratton, Wendy M Leisenring, et al.
Cancer|February 18, 2017
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupDavid O Walterhouse, Alberto S Pappo, Jane L Meza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupDavid O Walterhouse, Alberto S Pappo, Jane L Meza, et al.
Pageof 14

Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Cancer|January 22, 2005
The feasibility of adjuvant interferon alpha-2b in children with high-risk melanomaFariba Navid, Wayne L Furman, Martin Fleming, et al.
Journal of Pediatric Surgery|March 26, 2002
Perianal rhabdomyosarcoma presenting as a perirectal abscess: A report of 11 casesD Ashley Hill, Louis P Dehner, Kenneth W Gow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2002
Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhabdomyosarcoma soft tissue sarcomaSheri L Spunt, D Ashley Hill, Alison M Motosue, et al.
Pediatric Blood & Cancer|May 17, 2024
Clinical features and outcomes of young patients with low-grade non-rhabdomyosarcoma soft tissue sarcomas treated with a risk-based strategy: A report from Children's Oncology Group study ARST0332David P Douglass, Cheryl M Coffin, R Lor Randall, et al.
Pediatric Blood & Cancer|February 8, 2011
Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology GroupDavid O Walterhouse, Jane L Meza, John C Breneman, et al.
Sarcoma|July 7, 2015
Mesenchymal Chondrosarcoma in Children and Young Adults: A Single Institution Retrospective ReviewMichael W Bishop, Jessica M Somerville, Armita Bahrami, et al.
Cancer|March 17, 2006
Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the St. Jude Children's Research Hospital experienceFariba Navid, Victor M Santana, Catherine A Billups, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Melanoma Among Adult Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor StudySeth J Rotz, Kayla Stratton, Wendy M Leisenring, et al.
Cancer|February 18, 2017
Reduction of cyclophosphamide dose for patients with subset 2 low-risk rhabdomyosarcoma is associated with an increased risk of recurrence: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupDavid O Walterhouse, Alberto S Pappo, Jane L Meza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 2014
Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology GroupDavid O Walterhouse, Alberto S Pappo, Jane L Meza, et al.
Pageof 14